Article or book title, author's surname, DOI

Serum Insulin-Like Growth Factors 1 and 2 and Insulin-Like Growth Factors Binding Proteins 1 and 3 in CIN and Invasive Cervical Cancer as Perspective Markers of Disease Progression

L.I. Korolenkova1, D.N. Kushlinsky2, E.S. Gershtein3, V.D. Ermilova4, E.K. Dvorova5

research article Pages: 21-25

  1. 1 к.м.н., ст. науч. сотрудник, поликлиника, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
  2. 2 врач-гинеколог, ФГБУ «Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова» Минздравсоцразвития РФ
  3. 3 д.б.н., профессор, лаборатория клинической биохимии, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
  4. 4 к.м.н., вед. науч. сотрудник, отдел патологической анатомии опухолей человека, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
  5. 5 ведущий инженер, лаборатория клинической биохимии, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН

Abstract

Cell proliferation and apoptosis are especially important for the formation of CIN and invasive cervical cancer. Insulin-like growth factors (IGF) 1 and 2, and several IGF-binding proteins (IGFBP) have been shown to play an important role in regulation of cell proliferation, differentiation and apoptosis. 64 patients with cervical neoplasia (22 CIN1-2, 7 microinvasive and 35 invasive cancer) and 16 women with no signs of cervical neoplasia were included in the study. The chosen stages present the important hallmarks of cancerogenesis: induction (CIN1-2), rupture of basal membrane (microinvasive cancer) and evident invasion (1B1 invasive cancer). Serum IGF-1, IGF-2, IGFPB-1, IGFPB-3 levels were measured by enzyme-linked immunoassays before treatment and IGFBP-1/IGFPB-3 rate was also assessed. In invasive cancer significant IGF-1, IGF-2, IGFPB-3 down-regulation as well as increase in IGFPB-1 level and IGFPB-1/IGFPB-3 rate was revealed. The only significant changes in microinvasive cancer were IGF-1 decrease and IGFPB-1 increase. Similar although not significant changes were seen in CIN1-2 patients thus confirming these proteins to be involved in cervical cancerogenesis. IGF family proteins might be perspective progression and «latent» invasion markers for patients with high-grade epithelial lesions. Lower IGF-1, IGF-2 and IGFPB-3 values as well as increased IGFPB-1 may reveal invasive cervical lesions. There is a need for further investigations to assess the critical IGF-1, IGF-2, IGFBP-3, IGFPB-1, IGFBP-1/IGFBP-3 endpoints associated with invasion.

How to cite

Короленкова Л.И., Кушлинский Д.Н., Герштейн Е.С., Ермилова В.Д., Дворова Е.К. Инсулиноподобные факторы роста сыворотки крови больных цервикальной интраэпителиальной неоплазией и инвазивным раком шейки матки как перспективные маркеры прогрессии заболевания // Вопросы биологической, медицинской и фармацевтической химии. 2012. № 10. С. 21–25.

References
  1. Короленкова Л.И. Диагностика неизлеченности и рецидивов преинвазивного и микроинвазивного рака шейки матки с помощью ВПЧ-тестирования методом гибридного захвата // Вопросы биологической, медицинской и фармацевтической химии. 2011. № 12. С. 23-27.
  2. McCredie M.R., Sharples K.J., Paul C. et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study // Lancet Oncol. 2008. V. 9. P. 425-434.
  3. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis // J. Natl. Cancer Inst. 2000. V. 92. P. 690-698.
  4. Prétet J.L., Jacquard A.C., Carcopino X., Monnier-Benoit S. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study // Int. J. Cancer. 2008. V. 122. № 2. P. 424-427.
  5. Bosch F.X. Global Burden of HPV Associated Diseases // Workshop book, 25th International Conference Clinical and Educational Workshop. 2009. P. 44-83.
  6. Kovanda A., Juvan U., Sterbenc A. et al.Pre-vaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia //Acta Dermatovenerol Alp Panonica Adriat. 2009. V. 18. № 2. P. 47-52.
  7. Кушлинский Н.Е., Тимофеев Ю.С. Система инсулиноподобных факторов роста // Вопросы биологической, медицинской и фармацевтической химии. 2011. № 12. С. 3-22.
  8. Lee S.W., Lee S.Y., Lee S.R., Ju W., Kim S.C. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia // J. Gynecol. Oncol. 2010. V. 21. № 3. P. 174-180.
  9. Pollak M. Insulin-like growth factor physiology and cancer risk // Eur. J. Cancer.2000. V. 36. P. 1224-1228.
  10. Hirano S., Ito N., Takahashi S., Tamaya T.Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers // Eur. J. Gynaecol. Oncol. 2004. V. 25. № 2. P. 187-191.
  11. Wu X., Tortolero-Luna G., Zhao H., Phatak D., Spitz M.R., Follen M. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix // Clin. Cancer Res. 2003. V. 9. P. 3356-3361.
  12. Serrano M.L., Romero A., Cendales R., Sanchez-Gomez M., Bravo M.M. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer // Biomedica. 2006. V. 26. P. 258-268.